Medicare Enrolled
Dr. Adam Khadbai, M.D.
Family Medicine · Weatherford, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Khadbai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khadbai? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khadbai
Dr. Adam Khadbai is a family medicine in Weatherford, TX, with 13 years in practice. Based on federal Medicare data, Dr. Khadbai performed 2,563 Medicare services across 1,472 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khadbai received a total of $17,913 from 71 pharmaceutical and/or device companies across 1074 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khadbai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice▲ Top 10% volume in TX$ $17,913 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,563
Medicare services
Top 10% in TX for family medicine
1,472
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~197 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 900 | $79 | $283 |
| Dexamethasone injection (steroid) | 306 | $0 | $5 |
| Office visit, established patient (20-29 min) | 227 | $57 | $192 |
| Annual wellness visit, follow-up | 213 | $126 | $299 |
| Hemoglobin A1c test (diabetes monitoring) | 148 | $9 | $40 |
| Drug injection, under skin or into muscle | 116 | $10 | $14 |
| Flu vaccine, high-dose | 77 | $72 | $75 |
| Automated urinalysis | 55 | $2 | $26 |
| Advance care planning consultation, first 30 min | 54 | $80 | $229 |
| Assessment of emotional or behavioral problems | 45 | $3 | $10 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 44 | $35 | $55 |
| Injection, ketorolac tromethamine, per 15 mg | 41 | $0 | $10 |
| Detection test by immunoassay with direct visual observation for influenza virus | 38 | $16 | $45 |
| Injection, methylprednisolone acetate, 80 mg | 38 | $8 | $15 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 35 | $1 | $15 |
| Office visit, established patient, complex (40-54 min) | 34 | $125 | $381 |
| Remote patient monitoring management, 20 min/month | 28 | $38 | $85 |
| New patient office visit (45-59 min) | 26 | $94 | $438 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 24 | $274 | $280 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 20 | $168 | $350 |
| New patient office visit, complex (60-74 min) | 17 | $120 | $548 |
| Remote patient monitoring device, 30 days | 16 | $38 | $85 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 16 | $32 | $113 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 16 | $162 | $436 |
| Electrocardiogram (EKG), 12-lead | 15 | $10 | $100 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 14 | $15 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,913
Total received (2018-2024)
Avg $2,559/year across 7 years
Top 1% in TX for family medicine
71
Companies
1,074
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,585 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$328 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,075
2023$3,594
2022$2,956
2021$3,054
2020$1,816
2019$1,999
2018$1,419
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$1,298
Novo Nordisk Inc
$1,292
ABBVIE INC.
$1,248
AstraZeneca Pharmaceuticals LP
$1,148
PFIZER INC.
$923
Amgen Inc.
$896
Sunovion Pharmaceuticals Inc.
$831
Teva Pharmaceuticals USA, Inc.
$707
Lilly USA, LLC
$697
AbbVie Inc.
$554
Sumitomo Pharma America, Inc.
$531
Astellas Pharma US Inc
$522
SANOFI-AVENTIS U.S. LLC
$479
Boehringer Ingelheim Pharmaceuticals, Inc.
$478
Mylan Specialty L.P.
$469
Corium, LLC
$450
Allergan Inc.
$442
ITI, Inc.
$422
Allergan, Inc.
$410
Supernus Pharmaceuticals, Inc.
$320
Otsuka America Pharmaceutical, Inc.
$313
Merck Sharp & Dohme Corporation
$307
Takeda Pharmaceuticals U.S.A., Inc.
$183
Nestle HealthCare Nutrition Inc.
$164
Abbott Laboratories
$161
Antares Pharma, Inc.
$144
Exact Sciences Corporation
$143
Adlon Therapeutics L.P.
$141
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$139
Merck Sharp & Dohme LLC
$136
AIMMUNE THERAPEUTICS, INC.
$128
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$122
Lundbeck LLC
$119
Bayer HealthCare Pharmaceuticals Inc.
$114
Eisai Inc.
$103
IRONSHORE PHARMACEUTICALS INC.
$90
Alkermes, Inc.
$87
Ironshore Pharmaceuticals Inc.
$85
IBSA Pharma Inc.
$77
VIVUS LLC
$77
Tris Pharma Inc
$76
Janssen Pharmaceuticals, Inc
$70
Biohaven Pharmaceutical Holding Company Ltd.
$62
Shire North American Group Inc
$61
Biohaven Pharmaceuticals, Inc.
$53
IDORSIA PHARMACEUTICALS US INC
$50
Medtronic, Inc.
$50
Cranial Technologies, Inc
$48
Bayer Healthcare Pharmaceuticals Inc.
$47
Insulet Corporation
$45
Amarin Pharma Inc.
$41
Optos, Inc.
$32
Circassia Pharmaceuticals Inc
$29
Currax Pharmaceuticals LLC
$25
Esperion Therapeutics, Inc.
$22
GRT US Holding, Inc.
$21
Ultragenyx Pharmaceutical Inc.
$19
Tolmar, Inc.
$18
MERZ NORTH AMERICA, INC.
$18
EISAI INC.
$17
NESTLE HEALTHCARE NUTRITION INC.
$16
Ironwood Pharmaceuticals, Inc
$16
Novartis Pharmaceuticals Corporation
$15
Tandem Diabetes Care, Inc.
$15
Xeris Pharmaceuticals, Inc.
$15
Noven Therapeutics, LLC
$14
Paratek Pharmaceuticals, Inc.
$14
Strongbridge US INC.
$13
Intuitive Surgical, Inc.
$12
Kowa Pharmaceuticals America, Inc.
$12
Genentech USA, Inc.
$12
Top 3 companies account for 21.4% of total payments
Associated products mentioned in payments ›
ADHANSIA XR · AIMOVIG · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · AUSTEDO · AZSTARYS · Aimovig · Amitiza · Austedo XR · Azstarys · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BOTOX · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · BYVALSON · Belviq · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CREON · Cologuard Collection Kit · DUZALLO · Da Vinci Surgical System · Dayvigo · Doc Band · Dyanavel XR · Dymista · ELIQUIS · EMGALITY · EUCRISA · FARXIGA · FASENRA · FLECTOR · FREESTYLE LIBRE · FreeStyle Libre · GEMTESA · GUARDIAN CONNECT · JANUVIA · JARDIANCE · JATENZO · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KEVEYIS · Kerendia · LINZESS · LONHALA MAGNAIR · LYBALVI · LYRICA · Livalo · MINIMED 770G · MOUNJARO · MYDAYIS · MYRBETRIQ · Myrbetriq · NEXLETOL · NFC-700 · NOCDURNA · NURTEC ODT · NUZYRA · OFEV · Omnipod · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · PREVNAR - 13 · PREVNAR 13 · QELBREE · QSYMIA · QULIPTA · QUVIVIQ · Qelbree · Qutenza · RELISTOR ORAL · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · TUDORZA PRESSAIR · Tirosint · UBRELVY · Uloric · VESICARE · VIBERZI · VRAYLAR · VYEPTI · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XYOSTED · Xelstrym · Xofluza · YUPELRI · Yupelri · ZENPEP · ZEPBOUND · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in TX.
Equivalent to $699 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
254
Per 100K population
160.7
County median income
$102,099
Nearest hospital
MEDICAL CITY WEATHERFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khadbai is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), and high industry engagement (low-engagement, top 1%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khadbai experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khadbai performed 900 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khadbai receive payments from pharmaceutical companies?
Yes. Dr. Khadbai received a total of $17,913 from 71 companies across 1,074 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khadbai's costs compare to other family medicines in Weatherford?
Dr. Khadbai's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khadbai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Weatherford
Browse family medicines in Weatherford ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology